2019
DOI: 10.1172/jci123462
|View full text |Cite
|
Sign up to set email alerts
|

RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(39 citation statements)
references
References 57 publications
0
39
0
Order By: Relevance
“…Conversely, the cullin 3 substrate adapter RhoBTB1 protects from arterial stiffness and hypertension through its ubiquitylation and the consequent degradation of the phosphodiesterase PDE5. Lower amounts of PDE5 lead to increased cGMP levels, which in turn promotes smooth muscle cell relaxation (Mukohda et al, 2019). This important role for cullin 3 in vascular smooth muscle cells is in good agreement with its degradation of RhoB in ECs, which also limits contraction and preserves endothelial integrity (Kovacěvicé t al., 2018;Sakaue et al, 2017).…”
Section: Ubiquitin-dependent Modifications In Vascular Diseasementioning
confidence: 65%
“…Conversely, the cullin 3 substrate adapter RhoBTB1 protects from arterial stiffness and hypertension through its ubiquitylation and the consequent degradation of the phosphodiesterase PDE5. Lower amounts of PDE5 lead to increased cGMP levels, which in turn promotes smooth muscle cell relaxation (Mukohda et al, 2019). This important role for cullin 3 in vascular smooth muscle cells is in good agreement with its degradation of RhoB in ECs, which also limits contraction and preserves endothelial integrity (Kovacěvicé t al., 2018;Sakaue et al, 2017).…”
Section: Ubiquitin-dependent Modifications In Vascular Diseasementioning
confidence: 65%
“…Another interpretation of these data could be that cGMP is produced but is rapidly degraded by PDE5, the main PDE involved in cGMP degradation in vascular smooth muscle cells. Indeed, we recently identified PDE5 as a CUL3 target (22). However, PDE5 expression was not increased but rather decreased in aorta of S-CUL3KO mice (data not shown).…”
Section: Discussionmentioning
confidence: 85%
“…BACURD1, another BTB domain-containing protein, is the substrate adaptor for RhoA (12). We identified another BTB domain-containing protein, RhoBTB1, as a PPARγ target gene in vascular smooth muscle that acts as a substrate adaptor for phosphodiesterase 5 (PDE5), a key protein regulating cGMP turnover (22). There are approximately 200 different BTB domain-containing proteins that may provide substrate specificity for a large number of protein substrates (23).…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, studies have shown that mutations (P467L or V290M) in the ligand-binding domain of PPARγ cause not only insulin resistance but also early-onset hypertension [ 86 , 87 ], indicating its role in BP regulation. Moreover, dominant negative mice model of PPARγ (S-P467L) in VSMCs developed arterial stiffness and vascular dysfunction, accompanied by hypertension [ 88 , 89 ]. These results indicate that PPARγ in VSMCs may play an essential role in regulating BP.…”
Section: Role Of Ups In the Regulation Of Vascular Functionmentioning
confidence: 99%